Indian dialysis chain NephroPlus is to become a listed company. The group has filed a draft red herring prospectus with India’s capital markets regulatory body, the Securities and Exchange Board of India.
Indian dialysis group NephroPlus has entered its third geography with the signing of a 10-year PPP to provide dialysis services in Uzbekistan at US$50 per session, CEO Vikram Vuppala tells HBI.
In the last ten years, Russia has lept from 120th on the World Bank’s ‘ease of doing business’ scale to 31st, beating China, India and Turkey. Are worries about risk now over-inflated? Panellists at HBI 2019’s session on Russia and the CIS discuss.
The general director of one of Russia's largest IVF groups, Ava-Peter, told HBI 2019 delegates that the company has plans to enter the Uzbekistani market. The announcement points to just how tough the situation has become for private IVF operators in Russia in recent years.
Unilever runs a global health and prevention programme in over 90 countries for its 169,000 employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.
Unilever runs a global health and prevention programme in over 90 countries for its 169,000 employees. How? What does Dr Thirumalai (known as Dr Raj) think of the private healthcare services sector? And what changes does he expect in the future? And what does he expect from digital health and AI? Dr Raj is also a non-executive independent director of Apollo Hospitals Enterprise and a speaker at HBI 2018 on April 10-11 in London.
Malaysia's sovereign wealth fund is interested in investing in the region's healthcare sector. Khazanah was the main backer of Pan-Asian hospital group IHH - and remains a big shareholder.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
